LOGIFLOX 400 mg, film-coated tablet scored 3 tablets
Active ingredients: Lomefloxacin hydrochloride, Lomefloxacin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored3 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOGIFLOX 400 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 3 comprimé(s)
- Marketing authorisation holder
- BIOCODEX BENELUX (BELGIQUE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69340304CIP73345975CIP133400933459758Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LOMÉFLOXACINEcomprimé | 441,6 mg · un comprimé | SA |
| LOMÉFLOXACINE BASEcomprimé | 400 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.